These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2844068

  • 21. Mechanisms for lipoxin A4 induced neutrophil dependent cytotoxicity for human endothelial cells.
    Bratt J, Lerner R, Ringertz B, Palmblad J.
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():419-21. PubMed ID: 7732886
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lipoxin-induced migration of fish leukocytes.
    Sharp GJ, Pettitt TR, Rowley AF, Secombes CJ.
    J Leukoc Biol; 1992 Feb; 51(2):140-5. PubMed ID: 1331277
    [Abstract] [Full Text] [Related]

  • 24. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC, Wood LJ, Foster M, Gueremy T.
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
    Clish CB, Levy BD, Chiang N, Tai HH, Serhan CN.
    J Biol Chem; 2000 Aug 18; 275(33):25372-80. PubMed ID: 10837478
    [Abstract] [Full Text] [Related]

  • 27. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases.
    Maderna P, Cottell DC, Berlasconi G, Petasis NA, Brady HR, Godson C.
    Am J Pathol; 2002 Jun 18; 160(6):2275-83. PubMed ID: 12057930
    [Abstract] [Full Text] [Related]

  • 28. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M, Maddox JF, Serhan CN.
    J Immunol; 1996 Sep 01; 157(5):2149-54. PubMed ID: 8757340
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Arachidonic acid, leukotriene B4, and neutrophil activation.
    Naccache PH, Sha'afi RI.
    Ann N Y Acad Sci; 1983 Sep 01; 414():125-39. PubMed ID: 6322649
    [No Abstract] [Full Text] [Related]

  • 32. Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium.
    Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V.
    J Biol Chem; 2003 Mar 28; 278(13):10879-84. PubMed ID: 12500974
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lipoxin A4 induces neutrophil-dependent cytotoxicity for human endothelial cells.
    Bratt J, Lerner R, Ringertz B, Palmblad J.
    Scand J Immunol; 1994 Apr 28; 39(4):351-4. PubMed ID: 8146594
    [Abstract] [Full Text] [Related]

  • 35. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 36. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN.
    J Immunol; 2003 Jun 15; 170(12):6266-72. PubMed ID: 12794159
    [Abstract] [Full Text] [Related]

  • 37. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium.
    Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR.
    J Clin Invest; 1994 Feb 15; 93(2):499-508. PubMed ID: 7906693
    [Abstract] [Full Text] [Related]

  • 38. Granulocyte response to oxidized FMLP. Evidence for partial inactivation of FMLP.
    Van Dyke K, Castranova V, Van Dyke CJ, Ma J, Michaux K, Mollison KW, Carter GW.
    Inflammation; 1984 Mar 15; 8(1):87-99. PubMed ID: 6325346
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.